Studies on the formation of the lactone and acid form of the main metabolite of mefruside
Schlossmann, K.; Pütter, J.
Arzneimittel-Forschung 23(2): 255-262
1973
ISSN/ISBN: 0004-4172 PMID: 4739838 Document Number: 68867
Document emailed within 1 workday
Related Documents
Cazzulani, P.; Pietra, C.; Abbiati, G.A.; Ceserani, R.; Oliva, D.; Civelli, M.; Tajana, A.; Nardi, D. 1988: Pharmacological activities of the main metabolite of flavoxate 3-methylflavone-8-carboxylic acid Arzneimittel-Forschung 38(3): 379-382Ding, J-Jie.; Jiao, Z.; Yu, Y-Qiu.; Shi, X-Jin. 2007: Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone Yao Xue Xue Bao 42(6): 631-638
Norman, R.L.; Wood, A.W. 1984: O-Hydroxyphenylethanol, a novel lactone ring-opened metabolite of coumarin Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(5): 543-549
Shaw, P.N.; Tseti, J.; Warburton, S.; Adedoyin, A.; Houston, J.B. 1986: Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(2): 271-276
Xu, X.; Guo, P.; Song, Y.; Li, Z. 1991: The contents of gamma-aminobutyric acid and glutamic acid in brain affected by coriaria lactone Hua Xi Yi Ke da Xue Xue Bao 22(2): 213-215
Rao, S.S. 1969: Clinical assessment of chelating agents and lactones as calculus solvents. a study on the role of (A) malic acid, (B) cysteine hydrochloride, and (C) gluconic acid lactone Indian Journal of Medical Research 57(2): 391-398
Fujita, S.; Ikezono, K.; Umezato, M.; Hosoki, E.; Toba, Y.; Ishikawa, M.; Kusunoki, A.; Shintani, S. 1992: General pharmacological properties of the main metabolite of flosequinan Arzneimittel-Forschung 42(10): 1212-1222
Hu, L.; Wang, Z.; Xu, R.; Ma, J.; Wang, X.; Zhang, X. 2011: Determination of bupropion and its main metabolite in rat plasma by LC-MS and its application to pharmacokinetics Die Pharmazie 66(12): 924-928
Gladigau, V.; Ehret, I.; Hengy, H. 1977: TLC-method for quantitative densitometric determination of piprozoline and its main metabolite using internal standards Arzneimittel-Forschung 27(2b): 499-502
Hänni, R.; Hervouet, D.; Busslinger, A. 1979: Determination of an aromatic retinoid and its main metabolite by high-performance liquid chromatography Journal of Chromatography 162(4): 615-621
Hengy, H.; Vollmer, K.O.; Gladigau, V.; Kölle, E.U. 1980: Assay of etozolin and its main metabolite, ozolinone, in plasma by high performance liquid chromatography Arzneimittel-Forschung 30(10): 1788-1790
Maffei Facino, R.; Carini, M.; Aldini, G.; Calloni, M.T. 1997: Hydroxynimesulide, the main metabolite of nimesulide, prevents hydroperoxide/hemoglobin-induced hemolysis of rat erythrocytes Drugs under Experimental and Clinical Research 23(5-6): 157-165
Greter, J.; Lindstedt, S.; Steen, G. 1983: 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease Clinical Chemistry 29(3): 434-437
Goisis, M.; Oppo, G.T. 1973: Clinical results with a new non-steroid estrogen: tetrahydroderivative of mu-lactone of 6(6-10 Dihydroxyundecyl) beta-resorcilic acid Minerva Ginecologica 25(6): 332-359
Porubek, D.J.; Grillo, M.P.; Baillie, T.A. 1989: The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(2): 123-130
Moch, D.; Schewe, T.; Kühn, H.; Schmidt, D.; Buntrock, P. 1990: The linoleic acid metabolite 9DS-hydroxy-10,12(E,Z)-octadecadienoic acid is a strong proinflammatory mediator in an experimental wound healing model of the rat Biomedica Biochimica Acta 49(4): 201-207
Lee, C-Lin.; Wang, J-Jye.; Pan, T-Ming. 2006: Synchronous analysis method for detection of citrinin and the lactone and acid forms of monacolin K in red mold rice Journal - Association of Official Analytical Chemists 89(3): 669-677
Lennernäs, H.; Renberg, L.; Hoffmann, K.J.; Regårdh, C.G. 1993: Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(3): 435-440
Erbler, H.C. 1979: Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats Acta Endocrinologica 90(1): 147-156
Eadsforth, C.V.; Logan, C.J.; Page, J.A.; Regan, P.D. 1985: N-Butylglycidyl ether: the formation of a novel metabolite of an epoxide Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(2): 263-264